Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceGELFOAM (ABSORBABLE GELATIN) POWDER,USP
Generic NameAgent, absorbable hemostatic, collagen based
Regulation Number878.4490
ApplicantPFIZER, INC.
235 EAST 42ND ST.
NEW YORK, NY 10017
PMA NumberN18286
Supplement NumberS025
Date Received04/17/2013
Decision Date06/03/2013
Product Code LMF 
Advisory Committee General & Plastic Surgery
Supplement TypeSpecial (Immediate Track)
Supplement Reason Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review Granted? No
Combination ProductYes
Approval Order Statement  
APPROVAL FOR LABEL CHANGES TO THE INSTRUCTIONS FOR USE: FOR THE FOLLOWING DEVICE ITERATIONS:1) GELFOAM PLUS -ORIGINAL SPONGE IFU- NEEDLELESS;2) GELFOAM PLUS- POWDER IFU-NEEDLELESS; 3) GELFOAM PLUS - COMPRESSED SPONGE IFU NEEDLELESS;4) GELFOAM ABSORBABLE GELATIN) SPONGE; 5) GELFOAM (ABSORBABLE GELATIN) DENTAL SPONGE; 6) GELFOAM (ABSORBABLE GELATIN) COMPRESSED SPONGE; AND 7) GELFOAM (ABSORBABLE GELATIN) POWDER.ADD THE PRECAUTIONARY STATEMENT:POSITIONING OF THE PATIENT RESULTING IN NEGATIVE PERIPHERAL VENOUS PRESSURE DURING A PROCEDURE HAS BEEN REPORTED TO BE A CONTRIBUTING FACTOR RESULTING IN LIFE-THREATENING THROMBOEMBOLIC EVENTS.2. FOR THE FOLLOWING DEVICE ITERATIONS:1) GELFOAM (ABSORBABLE GELATIN) SPONGE; 2) GELFOAM (ABSORBABLE GELATIN) DENTAL SPONGE; 3) GELFOAM (ABSORBABLE GELATIN) COMPRESSED SPONGE; AND 4) GELFOAM (ABSORBABLE GELATIN) POWDER.MAKE MINOR CHANGES TO THE EXISTING PRECAUTIONARY STATEMENT: ALTHOUGH THE SAFETY AND EFFICACY OF THE COMBINED USE OF GELFOAM WITH OTHER AGENTS SUCH AS TOPICAL THROMBIN HAS NOT BEEN EVALUATED IN PHARMACIA- CONTROLLED CLINICAL TRIALS, IF IN THE PHYSICIANS JUDGMENT CONCURRENT USE OF TOPICAL THROMBIN OTHER AGENTS IS MEDICALLY ADVISABLE, THE PRODUCT LITERATURE FOR THAT AGENT SHOULD BE CONSULTED FOR COMPLETE PRESCRIBING INFORMATION.
-
-